Form 4 for SER Serina Therapeutics, Inc.
Accepted 2026-04-21 15:45:42 ET · period of report 2026-03-31 · accession 0001329505-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 15:45 | 2026-03-31 | SER | Bailey Gregory | Dir | A - Grant | $1.94 | +59.7K | 126.9K | +89% | +$115.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-31 | A | A | 59,667 | $1.94 | 126,910 | D | — | — | (F1) These shares of common stock were issued for payment of accrued dividends on the reporting individuals Series A Convertible Preferred Stock issued on April 8, 2025. |